Steven Vogl in Bronx, New York

Home New York Bronx

Steven Vogl has Medical Oncology as his primary medical specialty. Their primary office is: 111 E 210th St in Bronx, New York.

They're a part of the: Montefiore Medical Center medical group which has around 2,023 members. You can call their office at 718-920-4321 to schedule an appointment. , license information, procedures and more. They attended Sorry, his university is not listed and graduated in 1970 (around 54 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Steven Vogl Office Phone and Directions

Steven Vogl
Montefiore Medical Center
111 E 210th St
Bronx, New York 10467
718-920-4321

Patient Ratings
Please rate your experience with Steven Vogl below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 718-920-4321

Enter a starting address:

Healthcare Info for Steven Vogl

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1970
The Primary Medical Specialty for Steven Vogl is listed as: Medical Oncology
Approximate Years of Experience: 54
PAC (PECOS ID)#: 2466587209
NPI #: 1477516755
NPI Created On: 04/08/2006
NPI Last Updated Listed as: 07/09/2007
Primary Taxonomy Code: 207RH0003X
License Number:
110504
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana

They are listed as accepting new patients.

Languages spoken by staff include: English, German.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Ct scan of neck
Ct scan chest
Ct scan of abdomen and pelvis
Urinalysis, manual test
Complete blood cell count (red cells, white blood cell, platelets), automated test
Routine ekg using at least 12 leads including interpretation and report
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Infusion, normal saline solution, sterile (500 ml = 1 unit)

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342623

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Drug or Biological: Drug

Product Category #4: ONCOLOGY

Name of Drug #4: SANDOSTATIN

Associated Drug #4: 0078-0181-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342627

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Drug or Biological: Drug

Product Category #4: ONCOLOGY

Name of Drug #4: SANDOSTATIN

Associated Drug #4: 0078-0181-01

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342643

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342631

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Drug or Biological: Drug

Product Category #4: ONCOLOGY

Name of Drug #4: SANDOSTATIN

Associated Drug #4: 0078-0181-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: LUTATHERA

Open Associated Drug #1: 69488-003-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Drug or Biological: Drug

Product Category #4: ONCOLOGY

Name of Drug #4: SANDOSTATIN

Associated Drug #4: 0078-0181-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Drug or Biological: Drug

Product Category #4: ONCOLOGY

Name of Drug #4: SANDOSTATIN

Associated Drug #4: 0078-0181-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342655

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813342659

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Medical Oncology Professionals in Bronx

1.
Matthew Lee

111 E 210th St
Bronx, NY
Montefiore Medical Center

2.
Enrico Castellucci

111 E 210th St
Bronx, NY
Montefiore Medical Center

3.
Adilia Hormigo MD

111 E 210th St
Bronx, NY
Montefiore Medical Center

4.
Mark Ramirez

111 E 210th St
Bronx, NY
Montefiore Medical Center

5.
Nishi Shah

111 E 210th St
Bronx, NY
Montefiore Medical Center

6.
Yvonne Saenger

111 E 210th St
Bronx, NY
Montefiore Medical Center

Providers in Montefiore Medical Center

1.Ahmed Abdul Rah Abbasi

600 E 233rd St
Bronx Ny 10466-2604
Montefiore Medical Center
Hospitalist

2.Nidal Abdel Muhdi

111 E 210th St
Bronx Ny 10467-2401
Montefiore Medical Center
General Surgery

3.Abier Abdelnaby

111 E 210th St
Bronx Ny 10467-2401
Montefiore Medical Center
Colorectal Surgery (proctology)

4.Andrew Abdou

111 E 210th St
Bronx Ny 10467-2401
Montefiore Medical Center
Physical Medicine And Rehabilitation

5.Aryeh Abelow

111 E 210th St
Bronx Ny 10467-2401
Montefiore Medical Center
Cardiovascular Disease (cardiology)

6.Arthur Abelow

111 E 210th St
Bronx Ny 10467-2401
Montefiore Medical Center
Gastroenterology

View all 2,023 members of Montefiore Medical Center medical group